Ratings Intuitive Surgical, Inc.

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 02:58:50 2025-01-21 pm EST			5-day change	1st Jan Change
602.35 ^USD	+1.64%		+11.66%	+15.28%

01:38pm	Intuitive to Establish Direct Presence in Europe With Acquisition	DJ
01:23pm	Intuitive to Have Direct Presence in Italy, Portugal, Spain by Acquiring Distributor Businesses	MT

Summary: Intuitive Surgical, Inc.

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Highlights: Intuitive Surgical, Inc.

Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 56% by 2026.
The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
The group's activity appears highly profitable thanks to its outperforming net margins.
Thanks to a sound financial situation, the firm has significant leeway for investment.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Historically, the company has been releasing figures that are above expectations.

Weaknesses: Intuitive Surgical, Inc.

With an expected P/E ratio at 99.63 and 88.05 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
Based on current prices, the company has particularly high valuation levels.
The company appears highly valued given the size of its balance sheet.
The company is highly valued given the cash flows generated by its activity.

Ratings Chart: Intuitive Surgical, Inc.

Source: Surperformance

ESG chart: Intuitive Surgical, Inc.

Source: MSCI

Sector Comparison:

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Fundamentals	Composite Valuation	Composite Momentum	Capi. ($)
	INTUITIVE SURGICAL, INC.				211B
	THERMO FISHER SCIENTIFIC INC.				214B
	DANAHER CORPORATION				172B
	BOSTON SCIENTIFIC CORPORATION				145B
	SIEMENS HEALTHINEERS AG				60.64B
	AGILENT TECHNOLOGIES, INC.				42.09B
	EDWARDS LIFESCIENCES CORPORATION				41.16B
	GE HEALTHCARE TECHNOLOGIES INC.				38.72B
	SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.				39.16B
	RESMED, INC.				35.21B
	Average				99.97B
	Weighted average by Cap.

See all sector ratings

Investor Rating

Trading Rating

ESG MSCI

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

ESG

Environment

Social

Governance

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes